Defining heart failure end points in ST-segment elevation myocardial infarction trials: integrating past experiences to chart a path forward.
Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Zubin J
ZJ
Eapen
W H Wilson
WH
Tang
G Michael
GM
Felker
Adrian F
AF
Hernandez
Kenneth W
KW
Mahaffey
A Michael
AM
Lincoff
Matthew T
MT
Roe
D002986:Clinical Trials as Topic / Q000379:methods*; D023381:Endpoint Determination; D006333:Heart Failure / Q000175:diagnosis / Q000209:etiology* / Q000401:mortality; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000401:mortality / Q000628:therapy*; D009204:Myocardial Revascularization / Q000009:adverse effects / Q000401:mortality; D011237:Predictive Value of Tests; D012107:Research Design; D018570:Risk Assessment; D012307:Risk Factors; D009626:Terminology as Topic; D013997:Time Factors; D016896:Treatment Outcome